Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
dMed-Clinipace Announces Completion of US$50 Million Series C+ Financing from New Investors 2021-07-07 20:00
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA 2021-07-07 16:41
Elekta optimizes treatment times for cancer patients via proactive service innovation 2021-07-07 14:38
Innophys' MUSCLE SUIT Selling Steadily after Topping 20,000 Units 2021-07-07 14:00
CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy 2021-07-07 08:05
New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta® 2021-07-07 06:34
Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax 2021-07-07 01:43
Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody TST002 2021-07-06 21:36
Harbour BioMed Reports Positive Topline Results from Phase 2 Trial of Batoclimab (HBM9161) in Generalized Myasthenia Gravis 2021-07-06 21:06
Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility 2021-07-06 21:00
RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally 2021-07-06 21:00
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD 2021-07-06 18:00
Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market 2021-07-06 18:00
PolyU develops highly sensitive, microscopic optical fibre sensors with pioneering biomedical monitoring capability 2021-07-06 17:06
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate 2021-07-06 14:00
Bora Group announce the rebranding of Yuta Health to Bora Health 2021-07-06 13:31
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China 2021-07-06 08:00
Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF) 2021-07-06 08:00
South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology 2021-07-06 07:00
SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting 2021-07-05 19:42
1 374 375 376 377 378 896